{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:37:37Z","timestamp":1774442257996,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12029-019-00356-0","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T11:02:23Z","timestamp":1578740543000},"page":"125-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prognostic and Diagnostic Values of miR-506 and SPON 1 in Colorectal Cancer with Clinicopathological Considerations"],"prefix":"10.1007","volume":"52","author":[{"given":"Rozita","family":"Tamjidifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Tarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Sadeghzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Abolghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Poursaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Shomali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"356_CR1","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, et al. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065.","journal-title":"Nat Rev Dis Primers"},{"issue":"9838","key":"356_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(12)61031-9","volume":"380","author":"IM Lee","year":"2012","unstructured":"Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219\u201329.","journal-title":"Lancet"},{"issue":"7","key":"356_CR3","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/bjc.2013.91","volume":"108","author":"EJ Morris","year":"2013","unstructured":"Morris EJ, Penegar S, Whitehouse LE, Quirke P, Finan P, Bishop DT, et al. A retrospective observational study of the relationship between family history and survival from colorectal cancer. Br J Cancer. 2013;108(7):1502\u20137.","journal-title":"Br J Cancer"},{"issue":"35","key":"356_CR4","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","volume":"26","author":"H Hampel","year":"2008","unstructured":"Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26(35):5783\u20138.","journal-title":"J Clin Oncol"},{"issue":"9719","key":"356_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","volume":"375","author":"D Cunningham","year":"2010","unstructured":"Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et al. Colorectal cancer. Lancet. 2010;375(9719):1030\u201347.","journal-title":"Lancet"},{"key":"356_CR6","doi-asserted-by":"crossref","unstructured":"Shomali, N., et al., Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancer. 2019. 120(6): p. 9495\u20139505.","DOI":"10.1002\/jcb.28225"},{"key":"356_CR7","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.biopha.2017.11.046","volume":"97","author":"N Shirafkan","year":"2018","unstructured":"Shirafkan N, Mansoori B, Mohammadi A, Shomali N, Ghasbi M, Baradaran B. MicroRNAs as novel biomarkers for colorectal cancer: new outlooks. Biomed Pharmacother. 2018;97:1319\u201330.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"356_CR8","first-page":"2152","volume":"234","author":"M Ghasabi","year":"2019","unstructured":"Ghasabi M. et al. MicroRNAs in cancer drug resistance: basic evidence and clinical applications. 2019;234(3):2152\u201368.","journal-title":"MicroRNAs in cancer drug resistance: basic evidence and clinical applications"},{"issue":"1","key":"356_CR9","doi-asserted-by":"publisher","first-page":"107327481986278","DOI":"10.1177\/1073274819862784","volume":"26","author":"AO Fadaka","year":"2019","unstructured":"Fadaka AO, Pretorius A, Klein A. Biomarkers for stratification in colorectal cancer: MicroRNAs. Cancer Control. 2019;26(1):1073274819862784.","journal-title":"Cancer Control"},{"issue":"1","key":"356_CR10","doi-asserted-by":"publisher","first-page":"180212","DOI":"10.1098\/rsob.180212","volume":"9","author":"B Chen","year":"2019","unstructured":"Chen B, Xia Z, Deng YN, Yang Y, Zhang P, Zhu H, et al. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis. Open Biol. 2019;9(1):180212.","journal-title":"Open Biol"},{"key":"356_CR11","first-page":"405","volume":"6","author":"Y Dong","year":"2014","unstructured":"Dong Y, Yu J, Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res. 2014;6:405\u201322.","journal-title":"Cancer Manag Res"},{"issue":"35","key":"356_CR12","doi-asserted-by":"publisher","first-page":"38139","DOI":"10.18632\/oncotarget.5709","volume":"6","author":"Z Chen","year":"2015","unstructured":"Chen Z, et al. miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1. Oncotarget. 2015;6(35):38139\u201350.","journal-title":"Oncotarget"},{"issue":"38","key":"356_CR13","doi-asserted-by":"publisher","first-page":"62778","DOI":"10.18632\/oncotarget.11294","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, Ju J, Ni B, Wang H. The emerging role of miR-506 in cancer. Oncotarget. 2016;7(38):62778\u201388.","journal-title":"Oncotarget"},{"issue":"22","key":"356_CR14","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1016\/j.febslet.2011.10.021","volume":"585","author":"JL Tong","year":"2011","unstructured":"Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM, Xiao SD, et al. MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett. 2011;585(22):3560\u20138.","journal-title":"FEBS Lett"},{"issue":"1","key":"356_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrc.2015.05.092","volume":"464","author":"H Chang","year":"2015","unstructured":"Chang H, et al. Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma. Biochem Biophys Res Commun. 2015;464(1):45\u201350.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"356_CR16","first-page":"2697","volume":"5","author":"W Dai","year":"2015","unstructured":"Dai W, Huang HL, Hu M, Wang SJ, He HJ, Chen NP, et al. microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1). Am J Cancer Res. 2015;5(9):2697\u2013707.","journal-title":"Am J Cancer Res"},{"key":"356_CR17","doi-asserted-by":"crossref","unstructured":"Akbari M, et al. CD133: an emerging prognostic factor and therapeutic target in colorectal cancer. Cell Biol Int. 2019.","DOI":"10.1002\/cbin.11243"},{"key":"356_CR18","doi-asserted-by":"crossref","unstructured":"Karimi, L., et al., miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro. 2019. 234(11): p. 21359\u201321368.","DOI":"10.1002\/jcp.28745"},{"key":"356_CR19","unstructured":"Shanehbandi, D."},{"key":"356_CR20","doi-asserted-by":"crossref","unstructured":"Noorolyai, S., et al., The role of microRNAs involved in PI3-kinase signaling pathway in colorectal cancer. 2019. 234(5): p. 5664\u20135673.","DOI":"10.1002\/jcp.27415"},{"issue":"2","key":"356_CR21","first-page":"383","volume":"53","author":"L Vasile","year":"2012","unstructured":"Vasile L, Olaru A, Munteanu M, Ple\u015fea IE, Surlin V, Tudora\u015fcu C. Prognosis of colorectal cancer: clinical, pathological and therapeutic correlation. Romanian J Morphol Embryol. 2012;53(2):383\u201391.","journal-title":"Romanian J Morphol Embryol"},{"issue":"1","key":"356_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5732\/cjc.011.10245","volume":"32","author":"Y Jia","year":"2013","unstructured":"Jia Y, Guo M. Epigenetic changes in colorectal cancer. Chin J Cancer. 2013;32(1):21\u201330.","journal-title":"Chin J Cancer"},{"issue":"1\u20132","key":"356_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1023\/A:1025806911782","volume":"23","author":"Y Kondo","year":"2004","unstructured":"Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 2004;23(1\u20132):29\u201339.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"356_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3892\/ol.2017.5593","volume":"13","author":"F Wang","year":"2017","unstructured":"Wang F, Ma Y, Wang H, Qin H. Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer. Oncol Lett. 2017;13(3):1048\u201357.","journal-title":"Oncol Lett"},{"issue":"1\u20132","key":"356_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2015.11.008","volume":"468","author":"Z Lu","year":"2015","unstructured":"Lu Z, Zhang W, Gao S, Jiang Q, Xiao Z, Ye L, et al. MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA. Biochem Biophys Res Commun. 2015;468(1\u20132):8\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"356_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/hep.25691","volume":"56","author":"JM Banales","year":"2012","unstructured":"Banales JM, S\u00e1ez E, Uriz M, Sarvide S, Urribarri AD, Splinter P, et al. Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology. 2012;56(2):687\u201397.","journal-title":"Hepatology"},{"issue":"40","key":"356_CR27","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1038\/onc.2009.211","volume":"28","author":"C Coulouarn","year":"2009","unstructured":"Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 2009;28(40):3526\u201336.","journal-title":"Oncogene"},{"issue":"1","key":"356_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/1319-3767.37808","volume":"14","author":"A Ben Mousa","year":"2008","unstructured":"Ben Mousa A. Sorafenib in the treatment of advanced hepatocellular carcinoma. Saudi J Gastroenterol. 2008;14(1):40\u20132.","journal-title":"Saudi J Gastroenterol"},{"issue":"19","key":"356_CR29","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.7150\/jca.26350","volume":"9","author":"X Xu","year":"2018","unstructured":"Xu X, Tao Y, Shan L, Chen R, Jiang H, Qian Z, et al. The role of microRNAs in hepatocellular carcinoma. J Cancer. 2018;9(19):3557\u201369.","journal-title":"J Cancer"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00356-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-019-00356-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00356-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:05:13Z","timestamp":1628600713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-019-00356-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1007\/s12029-019-00356-0","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,11]]},"assertion":[{"value":"11 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}